Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gargi Ganguly, Sasanka Chakrabarti, Uttara Chatterjee & Luciano Saso. (2017) Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Design, Development and Therapy 11, pages 797-810.
Read now
Read now
Articles from other publishers (48)
Zhi Dong Zhou, Ling Xiao Yi, Dennis Qing Wang, Tit Meng Lim & Eng King Tan. (2023) Role of dopamine in the pathophysiology of Parkinson’s disease. Translational Neurodegeneration 12:1.
Crossref
Crossref
Mortimer Mamelak. (2023) The Treatment of Parkinson’s Disease with Sodium Oxybate. Current Molecular Pharmacology 16:5.
Crossref
Crossref
Sasanka Chakrabarti & Marco Bisaglia. (2023) Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products. Antioxidants 12:4, pages 955.
Crossref
Crossref
Eva Hényková, Michal Kaleta, Kateřina Klíčová, Gabriel Gonzalez, Ondřej Novák, Miroslav Strnad & Petr Kaňovský. (2022) Quantitative Determination of Endogenous Tetrahydroisoquinolines, Potential Parkinson’s Disease Biomarkers, in Mammals. ACS Chemical Neuroscience 13:23, pages 3230-3246.
Crossref
Crossref
Cleonice Creusa Santos, Thyago R. Cardim-Pires, Liana Shvachiy, Luis Arturo Fonseca-Fonseca, Patricia Muñoz, Áurea Maria A. N. Almeida, Ana Carla S. Costa, Jéssica Teles-Souza, Estael Ochoa-Rodríguez, Maria de Fátima Dias Costa, Fernando L. Palhano, Juan Segura-Aguilar, Deyse B. Barbosa, Mayra R. do Bomfim, Manoelito C. dos Santos Junior, Franco Henrique A. Leite, Samuel Silva da Rocha Pita, Silvia Lima Costa, Yanier Núñez-Figueredo, Tiago Fleming Outeiro, Débora Foguel & Victor Diogenes Amaral Silva. (2022) JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species. Neurotoxicity Research 40:6, pages 2135-2147.
Crossref
Crossref
Zhi Dong Zhou, Wuan Ting Saw, Patrick Ghim Hoe Ho, Zhi Wei Zhang, Li Zeng, Ya Yin Chang, Alfred Xu Yang Sun, Dong Rui Ma, Hong Yan Wang, Lei Zhou, Kah Leong Lim & Eng-King Tan. (2022) The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis. Cellular and Molecular Life Sciences 79:12.
Crossref
Crossref
Giulia Costa & Krystyna Gołembiowska. (2022) Neurotoxicity of MDMA: Main effects and mechanisms. Experimental Neurology 347, pages 113894.
Crossref
Crossref
Alexander K. Hurben, Luke N. Erber, Natalia Y. Tretyakova & Todd M. Doran. (2021) Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine. ACS Chemical Biology 16:11, pages 2581-2594.
Crossref
Crossref
Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson & Ted M. Dawson. (2022) Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection. Pharmacological Reviews 73:4, pages 1204-1268.
Crossref
Crossref
Mohammad Mehdi Gravandi, Sajad Fakhri, Seyede Nazanin Zarneshan, Akram Yarmohammadi & Haroon Khan. (2021) Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities. Metabolic Brain Disease 36:7, pages 1501-1521.
Crossref
Crossref
Raúl Valdes, Alicia Armijo, Patricia Muñoz, Kjell Hultenby, Andres Hagg, Jose Inzunza, Ivan Nalvarte, Mukesh Varshney, Bengt Mannervik & Juan Segura-Aguilar. (2021) Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes. Neurotoxicity Research 39:2, pages 182-190.
Crossref
Crossref
Iván Fernández-Cruz, Iván Sánchez-Díaz, Verónica Narváez-Padilla & Enrique Reynaud. (2020) Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila. IBRO Reports 9, pages 65-77.
Crossref
Crossref
Cleonice Creusa Santos, Patricia Muñoz, Áurea Maria A. N. Almeida, Juceni Pereira de Lima David, Jorge Mauricio David, Silvia Lima Costa, Juan Segura-Aguilar & Victor Diogenes Amaral Silva. (2020) The Flavonoid Agathisflavone from Poincianella pyramidalis Prevents Aminochrome Neurotoxicity. Neurotoxicity Research 38:3, pages 579-584.
Crossref
Crossref
Tae Yeon Kim, Eunju Leem, Jae Man Lee & Sang Ryong Kim. (2020) Control of Reactive Oxygen Species for the Prevention of Parkinson’s Disease: The Possible Application of Flavonoids. Antioxidants 9:7, pages 583.
Crossref
Crossref
Upasana Ganguly, Anindita Banerjee, Sankha Shubhra Chakrabarti, Upinder Kaur, Oishimaya Sen, Roberto Cappai & Sasanka Chakrabarti. (2020) Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease. Biochemical Journal 477:6, pages 1109-1122.
Crossref
Crossref
Dorit Ben-Shachar. (2019) The bimodal mechanism of interaction between dopamine and mitochondria as reflected in Parkinson’s disease and in schizophrenia. Journal of Neural Transmission 127:2, pages 159-168.
Crossref
Crossref
Rebekah G. Langston & Mark R. Cookson. 2020. Recent Advances in Parkinson's Disease. Recent Advances in Parkinson's Disease
217
270
.
Giovanna Galliciotti, Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D'Acunto & Elena Miranda. 2020. Genetics, Neurology, Behavior, and Diet in Dementia. Genetics, Neurology, Behavior, and Diet in Dementia
147
161
.
Zhou, Xie, Saw, Ho, Wang, Lei, Yi & Tan. (2019) The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson’s Disease (PD). Cells 8:8, pages 911.
Crossref
Crossref
Fiona Limanaqi, Francesca Biagioni, Carla Letizia Busceti, Larisa Ryskalin & Francesco Fornai. (2019) The effects of proteasome on baseline and methamphetamine-dependent dopamine transmission. Neuroscience & Biobehavioral Reviews 102, pages 308-317.
Crossref
Crossref
Juan Segura-Aguilar. (2019) The importance of choosing a preclinical model that reflects what happens in Parkinson's disease. Neurochemistry International 126, pages 203-209.
Crossref
Crossref
Upasana Ganguly, Anirban Ganguly, Oishimaya Sen, Gargi Ganguly, Roberto Cappai, Arghyadip Sahoo & Sasanka Chakrabarti. (2019) Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson’s Disease. Neurotoxicity Research 35:4, pages 898-907.
Crossref
Crossref
Juan Segura-Aguilar. (2019) On the Role of Aminochrome in Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Parkinson's Disease. Frontiers in Neuroscience 13.
Crossref
Crossref
Sandro Huenchuguala, Birgitta Sjödin, Bengt Mannervik & Juan Segura-Aguilar. (2018) Novel Alpha-Synuclein Oligomers Formed with the Aminochrome-Glutathione Conjugate Are Not Neurotoxic. Neurotoxicity Research 35:2, pages 432-440.
Crossref
Crossref
Fillipe M. de Araújo, Rafael S. Ferreira, Cleide S. Souza, Cleonice Creusa dos Santos, Tácio L.R.S. Rodrigues, Juliana Helena C. e Silva, Juciano Gasparotto, Daniel Pens Gelain, Ramon S. El-Bachá, Maria de Fátima D. Costa, José Claudio M. Fonseca, Juan Segura-Aguilar, Silvia L. Costa & Victor Diogenes A. Silva. (2018) Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures. NeuroToxicology 66, pages 98-106.
Crossref
Crossref
Sabah H. Enayah, Brigitte C. Vanle, Laurence J. Fuortes, Jonathan A. Doorn & Gabriele Ludewig. (2018) PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells. Toxicology 394, pages 93-101.
Crossref
Crossref
Poonam Goswami, Neeraj Joshi & Sarika Singh. (2017) Neurodegenerative signaling factors and mechanisms in Parkinson's pathology. Toxicology in Vitro 43, pages 104-112.
Crossref
Crossref
Fabio A. Zucca, Juan Segura-Aguilar, Emanuele Ferrari, Patricia Mu?oz, Irmgard Paris, David Sulzer, Tadeusz Sarna, Luigi Casella & Luigi Zecca. (2017) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease. Progress in Neurobiology 155, pages 96-119.
Crossref
Crossref
Tereza Nehybová, Jan Šmarda, Lukáš Daniel, Marek Stiborek, Viktor Kanický, Ivan Spasojevič, Jan Preisler, Jiří Damborský & Petr Beneš. (2017) Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. International Journal of Molecular Sciences 18:4, pages 729.
Crossref
Crossref
Eduard Bentea, Lise Verbruggen & Ann Massie. (2017) The Proteasome Inhibition Model of Parkinson’s Disease. Journal of Parkinson's Disease 7:1, pages 31-63.
Crossref
Crossref
Zhi Dong Zhou, Sushmitha Sathiyamoorthy, Dario C. Angeles & Eng King Tan. (2016) Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD). Molecular Brain 9:1.
Crossref
Crossref
Silvia Lima Costa, Victor Diogenes Amaral Silva, Cleide dos Santos Souza, Cleonice Creusa Santos, Irmgard Paris, Patricia Muñoz & Juan Segura-Aguilar. (2016) Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases. Neurotoxicity Research 30:1, pages 41-52.
Crossref
Crossref
David S. Goldstein, Courtney Holmes, Patti Sullivan, Deborah C. Mash, Ellen Sidransky, Alessandro Stefani, Irwin J. Kopin & Yehonatan Sharabi. (2015) Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & Related Disorders 21:9, pages 1013-1022.
Crossref
Crossref
Hyo Jin Son, Ji Hyun Choi, Ji Ae Lee, Dong Jin Kim, Kye Jung Shin & Onyou Hwang. (2015) Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson’s Disease Models. Journal of Molecular Neuroscience 56:2, pages 263-272.
Crossref
Crossref
Juan Segura-Aguilar & Richard M. Kostrzewa. (2015) Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update. Neurotoxicity Research 27:3, pages 328-354.
Crossref
Crossref
Carlos Cuevas, Sandro Huenchuguala, Patricia Muñoz, Monica Villa, Irmgard Paris, Bengt Mannervik & Juan Segura-Aguilar. (2014) Glutathione Transferase-M2-2 Secreted from Glioblastoma Cell Protects SH-SY5Y Cells from Aminochrome Neurotoxicity. Neurotoxicity Research 27:3, pages 217-228.
Crossref
Crossref
Patricia Muñoz, Catalina Melendez, Irmgard Paris & Juan Segura-Aguilar. 2015. Toxicity and Autophagy in Neurodegenerative Disorders. Toxicity and Autophagy in Neurodegenerative Disorders
205
223
.
David S. Goldstein, Irwin J. Kopin & Yehonatan Sharabi. (2014) Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders. Pharmacology & Therapeutics 144:3, pages 268-282.
Crossref
Crossref
Juan Segura-Aguilar, Irmgard Paris, Patricia Muñoz, Emanuele Ferrari, Luigi Zecca & Fabio A. Zucca. (2014) Protective and toxic roles of dopamine in Parkinson's disease. Journal of Neurochemistry 129:6, pages 898-915.
Crossref
Crossref
Zhi Dong Zhou, Fathima Shaffra Refai, Shao Ping Xie, Shin Hui Ng, Christine Hui Shan Chan, Patrick Ghim Hoe Ho, Xiao Dong Zhang, Tit Meng Lim & Eng King Tan. (2014) Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons. Free Radical Biology and Medicine 68, pages 220-233.
Crossref
Crossref
Marco Bisaglia, Roberta Filograna, Mariano Beltramini & Luigi Bubacco. (2014) Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?. Ageing Research Reviews 13, pages 107-114.
Crossref
Crossref
Patricia Mu?oz, Irmgard Paris, Laurie H. Sanders, J. Timothy Greenamyre & Juan Segura-Aguilar. (2012) Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1822:7, pages 1125-1136.
Crossref
Crossref
Neşe Tunçel, Orhan Tansel Korkmaz, Neslihan Tekin, Erol Şener, Fahrettin Akyüz & Mine İnal. (2011) Antioxidant and Anti-Apoptotic Activity of Vasoactive Intestinal Peptide (VIP) Against 6-Hydroxy Dopamine Toxicity in the Rat Corpus Striatum. Journal of Molecular Neuroscience 46:1, pages 51-57.
Crossref
Crossref
Uk Koo, Kung-Woo Nam, Ahrom Ham, Dahyun Lyu, Bora Kim, Sung-Jin Lee, Kyeong Ho Kim, Ki-Bong Oh, Woongchon Mar & Jongheon Shin. (2011) Neuroprotective Effects of 3α-Acetoxyeudesma-1,4(15),11(13)-trien-12,6α-olide Against Dopamine-Induced Apoptosis in the Human Neuroblastoma SH-SY5Y Cell Line. Neurochemical Research 36:11, pages 1991-2001.
Crossref
Crossref
Elizabeth A. Mazzio, Fran Close & Karam F.A. Soliman. (2011) The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease. International Journal of Molecular Sciences 12:1, pages 506-569.
Crossref
Crossref
Zhi Dong Zhou, Yu Hong Lan, Eng King Tan & Tit Meng Lim. (2010) Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration. Free Radical Biology and Medicine 49:12, pages 1856-1871.
Crossref
Crossref
Zhi Dong Zhou & Tit Meng Lim. (2010) Glutathione Conjugates with Dopamine-Derived Quinones to Form Reactive or Non-Reactive Glutathione-Conjugates. Neurochemical Research 35:11, pages 1805-1818.
Crossref
Crossref
Marco Bisaglia, Maria Eugenia Soriano, Irene Arduini, Stefano Mammi & Luigi Bubacco. (2010) Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: Implications for mitochondrial dysfunction in Parkinson disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1802:9, pages 699-706.
Crossref
Crossref